MedlinePlus backlinks to wellness facts from the Nationwide Institutes of Health and various federal federal government organizations. MedlinePlus also hyperlinks to wellness info from non-government Internet sites. See our disclaimer about external hyperlinks and our top quality rules.
Contraindicated (one)pentobarbital will lower the level or impact of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or influence of fentanyl transmucosal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Coadministration of fentanyl with CYP3A4 inducers could lead into a lessen in fentanyl plasma concentrations, insufficient efficacy or, maybe, progress of the withdrawal syndrome in a very individual that has designed Actual physical dependence to fentanyl.
pentobarbital will lower the level or impact of amiodarone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will reduce the level or result of parecoxib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital will lower the level or result of quinine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
Contraindicated (1)pentobarbital will decrease the level or impact of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or outcome of alosetron by influencing hepatic enzyme CYP2C9/ten metabolism. Minor/Significance Unknown.
pentobarbital will lower the extent or influence of dutasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.
pentobarbital will minimize the level or outcome of trazodone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will lessen the level or outcome of darifenacin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Contraindicated (1)pentobarbital will minimize the extent or effect of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Usage of naloxegol with robust CYP3A4 inducers is not encouraged
pentobarbital will lower the extent or result of artemether/lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration with solid CYP3A4 inducers can result in lessened serum concentrations Nembutal oral med syringe and loss of antimalarial efficacy
pentobarbital will lessen the extent or outcome of rabeprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.